Phenytoin pretreatment prevents hypoxic-ischemic brain damage in neonatal rats

Developmental Brain Research

Volumn 95, Issue 2, 1996, Pages 169-175

  Vartanian, Mark G ^a   Cordon, John J ^a   Kupina, Nancy C ^a   Schielke, Gerald P ^a   Posner, Avigail ^a   Raser, Kadee J ^a   Wang, Kevin K W ^a   Taylor, Charles P ^a  

^a PFIZER INC   (United States)

Author keywords

Calpain; Hypoxia; Ischemia; Neuroprotection; Rat pup; Sodium channel; Spectrin breakdown; Stroke

Indexed keywords

ANTICONVULSIVE AGENT; NEUROPROTECTIVE AGENT; PHENYTOIN; SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOLOGY; HYPOXIA; INTRAPERITONEAL DRUG ADMINISTRATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030565469     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-3806(96)00073-9     Document Type: Article

References (45)

1. [1] Andiné, P., Lehmann, A., Eilren, K., Wennberg, E., Kjeller, I., Nielsen, T. and Hagberg, H., The excitatory amino acid antagonist kynurenic acid administered after hypoxia-ischemia in neonatal rats offers neuroprotection, Neurosci. Lett., 90 (1988) 208-212.
2. [2] Barks, J.D.E., Post, M. and Tuor, U.I., Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat, Pediat. Res., 29 (1991) 558-563.
3. [3] Boehm, F.H., Liem, L.K., Stanton, P.K., Potter, P.E. and Moskal, J.R., Phenytoin protects against hypoxia-induced death of cultured hippocampal neurons, Neurosci. Lett., 175 (1994) 171-174.
4. [4] Boxer, P.A., Cordon, J.J., Mann, M.E., Rodolosi, L.C., Vartanian, M.G., Rock, D.M., Taylor, C.P. and Marcoux, F.W., Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat, Stroke, 21 (Suppl. III) (1990) 47-51.
5. [5] DeLorenzo, R.J., Phenytoin: Mechanisms of action. In: R. Levy, R. Mattson, B. Meldrum, J.K. Penry and F.E. Dreifuss (Eds.), Antiepileptic Drugs, 3rd edn., Raven Press, New York, 1989, pp. 143-158.
6. [6] Fern, R., Ransom, B.R., Stys, P.K. and Waxman, S.G., Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam, J. Pharmacol. Exp. Ther., 26 (1993) 1549-1555.
7. [7] Gordon, K.E., Simpson, J., Statman, D. and Silverstein, F.S., Effects of stroke on striatal amino acid efflux in rats studied with in vitro microdialysis, Stroke, 22 (1991) 928-932.
8. [8] Hajimohammadreza, I., Probert, A.W., Coughenour, L.L., Borosky, S.A., Boxer, P.A., Marcoux, F.W. and Wang, K.K.W., Inhibition of calmodulin-dependent protein kinase-II attenuates excitotoxic amino acid mediated neuronal death, J. Neurosci., 15 (1995) 4093-4101.
9. [9] Hansen, A.J., Effect of anoxia on ion distribution in the brain, Physiol. Rev., 65 (1985) 101-148.
10. [10] Hattori, H., Morin, A., Schwartz, P., Fujikawa, D. and Wasterlain, C., Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat, Neurology, 39 (1989) 713-718.
11. [11] Hayakawa, T., Hamada, Y., Maihara, Y., Hattori, H. and Mikawa, H., Phenytoin reduces neonatal hypoxic-ischemic brain damage in rats, Life Sci., 54 (1994) 387-392.
12. [12] Hayakawa, T., Higuchi, Y., Nigami, H. and Hattory, H., Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect, Eur. J. Pharmacol., 257 (1994) 131-136.
13. [13] Ikeda, M., Nakawaza, T., Kouchi, A., Kaneko, T. and Yamatsu, K., Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent: in vitro and in vivo evidence, Neurosci. Lett., 96 (1989) 202-206.
14. [14] Kass, I.S., Abramowicz, A.E., Cottrell, J.E. and Chambers, G., The barbiturate thiopental reduces ATP levels during anoxia but improves electrophysiological recovery and ionic homeostasis in the rat hippocampal slice, Neuroscience, 49 (1992) 537-543.
15. [15] Kuo, C.-C. and Bean, B.P., Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons, J. Pharmacol. Exp. Ther., 46 (1994) 716-725.
16. [16] Krall, R.L., Penry, J.K., White, B.G., Kupferberg, H.J. and Swinyard, E.A., Antiepileptic drug development: II. Anticonvulsant drug screening, Epilepsia, 19 (1978) 409-428.
17. [17] Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227 (1970) 680-685.
18. [18] Lekieffre, D. and Meldrum, B.S., The pyrimidine derivative, BW 1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study, Neuroscience, 56 (1993) 93-99.
19. [19] McDonald, J.W., Silverstein, F.S. and Johnston, M.V., MK-801 protects the neonatal brain from hypoxic-ischemic damage, Eur. J. Pharmacol., 140 (1987) 359-361.
20. [20] Nozaki, K. and Beal, M.F., Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats, J. Cerebral Blood Flow Metab., 12 (1992) 400-407.
21. [21] Palmer, C., Vannucci, R. and Towfighi, J., Reduction of perinatal hypoxic-ischemic brain damage with allopurinol, Pediatr. Res., 27 (1990) 332-336.
22. 3H]glutamate from rat hippocampal slices, Brain Res., 558 (1991) 127-130.
23. + channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs, Mol. Pharmacol., 40 (1991) 756-65.
24. [24] Rataud, J., Debarnot, F., Mary, V., Pratt, J. and Stutzmann, J-.M., Comparative study of voltage-dependent sodium channel blockers in focal ischaemia and electric convulsions in rodents, Neurosci. Lett., 172 (1994) 19-23.
25. [25] Rice, J.E., Vannucci, R.C., Brierly, J.B., The influence of immaturity on hypoxic-ischemic brain damage in the rat, Ann. Neurol., 9 (1981) 131-141.
26. [26] Rogawski, M.A., and Porter, R.J., Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol. Rev., 42 (1990) 223-286.
27. [27] Schauf, C.L., Zonisamide enhances slow sodium inactivation in Myxicola, Brain Res., 413 (1987) 185-189.
28. [28] Segal, M.M., Endogenous bursts underlie seizurelike activity in solitary excitatory hippocampal neurons in microcultures, J. Neurophysiol., 72 (1994) 1874-1884.
29. [29] Silverstein, F., Buchanan, K., Hudson, C. and Johnston, M., Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain, Stroke, 17 (1986) 477-482.
30. [30] Simon, R.P., Young, R.S., Stout, S. and Cheng, J., Inhibition of excitatory neurotransmission with kynurenate reduces brain injury in neonatal anoxia, Neurosci. Lett., 71 (1986) 361-364.
31. [31] Stanton, P.K. and Moskal, J.R., Diphenylhydantoin protects against hypoxia-induced impairment of hippocampal synaptic transmission, Brain Res., 546 (1991) 351-354.
32. [32] Stys, P.K., Ransom, B.R. and Waxman, S.G., Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability, J. Neurophysiol., 67 (1992) 236-240.
33. [33] Szatkowski, M. and Attwell, D., Triggering of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms, Trends Neurosci., 17 (1994) 359-365.
34. [34] Taft, W.C., Clifton, G.L., Blair, R.E. and DeLorenzo, R.J., Phenytoin protects against ischemia-produced neuronal cell death, Brain Res., 483 (1989) 143-148.
35. + channels as targets for neuroprotective drugs, Trends Pharmacol. Sci., 16 (1995) 309-316.
36. [36] Taylor, C.P., Burke, S.P. and Weber, M.L., Hippocampal slices: glutamate overflow and cellular damage from ischemia are reduced by sodium channel blockade, J. Neurosci. Methods, 59 (1995) 121-128.
37. [37] Towbin, H., Staehelin, T. and Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications, Proc. Natl. Acad. Sci. USA, 76 (1979) 4350-4354.
38. [38] Twombly, D.A., Yoshii, M. and Narahashi, T., Mechanisms of calcium channel block by phenytoin, J. Pharmacol. Exp. Ther., 246 (1988) 189-195.
39. [39] Vartanian, M.G., Cordon, J.J., Kupina, N.C., Schielke, J. and Taylor, C.P., Phenytoin and CI-953 attenuate hypoxic-ischemic brain damage in neonatal rats, Soc. Neurosci. Abstr., 19 (1993) 1657.
40. [40] Wang, K.K.W, and Yuen, P.-W., Calpain inhibition: an overview of its therapeutic potential, Trends Pharmacol. Sci., 15 (1994) 412-419.
41. [41] Wasterlain, C.G., Adams, L.M., Hattori, H. and Schwartz, P.H., Felbamate reduces hypoxic-ischemic brain damage in vivo, Eur. J. Pharmacol., 212 (1992) 275-278.
42. [42] Weber, M.L. and Taylor, C.P., Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials, Brain Res., 664 (1994) 167-177.
43. [43] Woodbury, D.M., Phenytoin: Mechanisms of action. In D.M. Woodbury, J.K. Penry and C.E. Pippenger (Eds.), Antiepileptic Drugs, 2nd edn., Raven Press, New York, 1982, pp. 269-282.
44. [44] Xie, Y., Dengler, K., Zacharias, E., Wilffert, B. and Tegtmeier, F., Effects of the sodium channel blocker tetrodotoxin (TTX) on cellular ion homeostasis in the rat brain subjected to complete ischemia, Brain Res., 652 (1994) 216-224.
45. [45] Yamasaki, Y., Kogure, K., Hara, H., Ban, H. and Akaike, N., The possible involvement of tetrodotoxin-sensitive ion channels in ischemic neuronal damage in the rat hippocampus, Neurosci. Lett., 121 (1991) 251-254.